London, England
Joined January 2018
- Tweets865
- Following630
- Followers346
- Likes1.5K
Polychronis Pavlidis retweeted
We are looking for an excellent & highly motivated postdoctoral researcher to join our team to develop an exciting project focused on the generation of Innate Lymphoid Cells #ILC for treatment of Inflammatory Bowel Disease #IBD using #organoids. Please RT!
kcl.ac.uk/jobs/109186-resear…
Polychronis Pavlidis retweeted
👌🏽 UK JCVI recommends Shingrix vaccination for severely immunosuppressed individuals in the UK to include 18-49 years = most people with IBD starting advanced therapies will be eligible. 🙏🏽@DHSCgovuk please consider upholding in the vaccination policy. gov.uk/government/publicatio…
Polychronis Pavlidis retweeted
Oral👄↔️gut💩#microbiome 🧫🦠 overlap🔃 in chronic liver disease #cirrhosis | virulence factors🌡️ | antimicrobial resistance #AMR 🧬
@Inst_of_Hep
@KCH_Research
@KingsCollegeNHS
@KCLImmunoMicro
@supportkings
@scilifelab
@BritSocGastro
@EASLnews
@clecliniclondon
@MicrobPredict
🆕Article in press❕
Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance
#OpenAccess here👉journal-of-hepatology.eu/art…
#LiverTwitter
Polychronis Pavlidis retweeted
As a small charity, every penny raised makes a huge difference. If you're getting together with friends this All Hallows' Eve, there's still time to raise a few bob and spread awareness about this rare disease. Here are a few simple & spooky ideas! 🎃
➡️ buff.ly/3NECBTa
Polychronis Pavlidis retweeted
The recent publications on the safety of patients with IBD in drug trials are much welcome, great work from colleagues across the IBD world 🏴 🇬🇧 🇺🇸 🇦🇺 🇨🇦 🇮🇹 🇫🇷
We are hugely indebted to patients participating in trials, yet they are exposed to excess harms by placebo treatments & prolonged steroid exposure.
We MUST insist on better trial design!
Polychronis Pavlidis retweeted
Exciting news! Thanks to The Helmsley Charitable Trust’s funding, IBUS is partnering with Motilent to launch a revolutionary eLearning platform for bowel ultrasound education.
Check this link for all the details: ibus-group.org/news/ibus-mot…
#IBUS #BowelUltrasound #eLearning
Polychronis Pavlidis retweeted
📢In 1999, a review of colonoscopy practice in the UK found that ‘training in colonoscopy is often inadequate and improved practice should result from better training’.
See how JAG rose to that challenge:
thejag.org.uk/our-history
#JAG30 #JAGFlashback
Polychronis Pavlidis retweeted
Medicine is difficult: there are no shortcuts bmj.com/content/387/bmj.q216… via @RCPEdin President @AndrewElder
Polychronis Pavlidis retweeted
We just published RCT of #prebiotics in older people in @NatureComms
Prebiotic inulin/FOS modified #microbiome as we expected, but no impact on muscle function💪🏽
But, surprise finding, cognition improved🧠
Paper with amazing @maryniloc @DrClaireSteves👉🏽nature.com/articles/s41467-0…
Polychronis Pavlidis retweeted
Any GI Physicians, nurses, dietitians and Respiratory colleagues interested in #cysticfibrosis 👀 this conference @BSGTrainees
@BritSocGastro
@cftrust
bsg.org.uk/Events/Endorsed-E…
Hear from the legendary @AntonEmmanuel2 @ProfWhelan amongst other leaders (and then there's me too!)
Polychronis Pavlidis retweeted
Excellent talk, packed audience, fantastic collaborator.
More info here:
cell.com/cell-host-microbe/a…
@schirmer_lab talk @Inst_of_Hep
#culturomics 👏👏👏
cell.com/cell-host-microbe/f…
@DrVishalCPatel @cellhostmicrobe
@KCLImmunoMicro @kingsmedicine @KCH_Research @AppgMicrobiome
Polychronis Pavlidis retweeted
The Shawcross Lab and @PROMISE_Trial are expanding ⬇️⬇️⬇️⬇️⬇️
We are looking for a Research Associate 1-2 yrs post PhD to work on #FMT mechanisms of action @kingsmedicine @kingshealth @KingsCollegeLon @DrLAEdwards @KCLImmunoMicro @Taams_Lab #livertwitter
kcl.ac.uk/jobs/083846-resear… – at Bromley, London
Polychronis Pavlidis retweeted
New 2-year postdoc position available in my lab @TheCrick to test novel therapies for #IBD and related diseases by targeting a master regulator of #macrophage-driven inflammation using antibody-drug conjugates and related tools. Apply here: crick.wd3.myworkdayjobs.com/… Pls retweet!
Polychronis Pavlidis retweeted
A survey we've created at @BowelsOfStMarks to look at local provisions of psychological support for IBD pts across UK. V v important topic + valuable to get an idea of what's going on to shape future initiatives. 10 mins. Thanks! Please spread!
gbr01.safelinks.protection.o…
Polychronis Pavlidis retweeted
It was a pleasure to speak with @JasminFoxSkelly for @newscientist about the impact of #oralbacteria in the #gut. @kingsdentistry @KingsCollegeLon
Checkout the article here:
newscientist.com/article/mg2…
Polychronis Pavlidis retweeted
Really excited to publish work from our group examining the real world effectiveness of biologics in IBD over long term followup of over 13,000 patients. A thread 1/12 academic.oup.com/ecco-jcc/ad…
Polychronis Pavlidis retweeted
And that's a wrap!
Two days of intense discussions, grading & formulating the next @BritSocGastro #IBD guidelines.
IBD colleagues from across the 4 nations & patient #advocates collaborating to produce the best evidence based treatment & care for those with #CD & #UC.
#TeamIBD
Polychronis Pavlidis retweeted
Open applications for funded PhD studentships at King's College London @KCL_MRCDTP
- very interesting projects! look at number 51 to work with me and @PolychronisP on identifying #IBD trajectories using #MachineLearning @KCLBHI
kcl-mrcdtp.com/apply/
Polychronis Pavlidis retweeted
📢IBD Newcastle 2023 will be held on Wednesday 29th November @UniofNewcastle
FREE to attend, @BritSocGastro-endorsed event with outstanding speakers for all healthcare professionals and will cover 'IBD across the life course’
Register for free: forms.office.com/e/iNTzKzrmi…
Polychronis Pavlidis retweeted
Congratulations to @Cogstack, for winning the Outstanding Achievements and Research Contributions - Social Good award @CogX_Festival! 👏 CogStack uses #AI to unlock information from patient health records, developed by our researchers with @KingsCollegeNHS & @UCLHresearch
ALT Quote card with logos of CogStack, CogX, NHS, NIHR and King's College London about winning the CogX awards: "“It’s fantastic to win this award. CogStack is an NHS home-grown, academically led platform specialising in electronic health records analytics and Clinical AI and this accolade reinforces our belief that our mission of building and delivering unique analytics and AI solutions in partnership with NHS Trusts is valuable and impactful. We could not have achieved this without the core CogStack teams that are co-located at each NHS Trust and our wider network of researchers, collaborators and funders.” Professor Richard Dobson, Professor James Teo, Tom Searle